ArticleClinical Medicine Insights. Oncology2021

Influence of GSTP1 Polymorphism on the Clinical Outcomes of Patients With Advanced NSCLC Receiving First-Line Bevacizumab-Based Regimen: A Real-World Retrospective Study.

Fei Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.